$UPXI
Upexi Inc Stock $upxi

$upxi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000147793223003603 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$17.81M	$24.22M	$27.09M
YoY Change	17.17%	135.79%	153.97%
Cost Of Revenue	$10.21M	$14.61M	$16.77M
YoY Change	24.66%	249.24%	323.87%
Gross Profit	$7.600M	$9.605M	$10.31M
YoY Change	8.42%	57.8%	53.64%
Gross Profit Margin	42.67%	39.66%	38.06%
Selling, General & Admin	$6.690M	$6.355M	$11.25M
YoY Change	-24.83%	40.49%	70.64%
% of Gross Profit	88.03%	66.17%	109.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$950.0K	$232.5K	$1.200M
YoY Change	-24.0%	61.97%	814.46%
% of Gross Profit	12.5%	2.42%	11.64%
Operating Expenses	$7.650M	$12.00M	$12.45M
YoY Change	-24.63%	95.26%	88.84%
Operating Profit	-$50.00K	-$2.399M	-$2.140M
YoY Change	-98.41%	3864.85%	-1919.73%
Interest Expense	-$2.380M	-$160.0K	-$1.790M
YoY Change	1387.5%	-2283.41%	-22201.49%
% of Operating Profit
Other Income/Expense, Net		$155.0K	-$1.793M
YoY Change		-1236.52%	6638.73%
Pretax Income	-$16.14M	-$2.554M	$3.630M
YoY Change	389.09%	3344.56%	3889.23%
Income Tax	-$2.600M	-$496.9K	$760.0K
% Of Pretax Income			20.94%
Net Earnings	-$15.36M	-$1.769M	$2.584M
YoY Change	486.26%	3258.25%	3885.78%
Net Earnings / Revenue	-86.24%	-7.3%	9.54%
Basic Earnings Per Share		-$0.11	$0.15
Diluted Earnings Per Share	-$0.79	-$0.11	$0.16
COMMON SHARES
Basic Shares Outstanding	18.09M shares	18.02M shares	17.96M shares
Diluted Shares Outstanding		18.02M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.490M	$1.180M	$4.510M
YoY Change	-37.2%	-73.8%	-31.62%
Cash & Equivalents	$4.492M	$1.181M	$4.508M
Short-Term Investments
Other Short-Term Assets	$1.250M	$1.810M	$1.940M
YoY Change	-83.87%	152.75%	238.36%
Inventory	$11.56M	$10.14M	$6.780M
Prepaid Expenses
Receivables	$7.164M	$5.347M	$8.870M
Other Receivables	$990.0K	$1.610M	$30.00K
Total Short-Term Assets	$25.46M	$20.10M	$22.12M
YoY Change	49.2%	95.84%	82.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.526M	$7.618M	$7.840M
YoY Change	-6.46%	-0.83%	5.37%
Goodwill	$10.25M	$15.06M
YoY Change	23.49%	76.44%
Intangibles	$13.57M	$17.31M
YoY Change	12.61%	262.82%
Long-Term Investments		$9.960M	$10.08M
YoY Change
Other Assets	$96.73K	$118.0K	$2.540M
YoY Change	-3.63%	70.9%	3577.54%
Total Long-Term Assets	$38.40M	$53.72M	$54.52M
YoY Change	22.17%	134.67%	135.94%
TOTAL ASSETS
Total Short-Term Assets	$25.46M	$20.10M	$22.12M
Total Long-Term Assets	$38.40M	$53.72M	$54.52M
Total Assets	$63.85M	$73.81M	$76.64M
YoY Change	31.68%	122.65%	117.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.970M	$2.636M	$4.160M
YoY Change	53.2%	104.46%	364.37%
Accrued Expenses	$3.366M	$4.172M	$4.800M
YoY Change	253.43%	452.13%	449.46%
Deferred Revenue
YoY Change
Short-Term Debt	$880.0K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.640M	$9.160M	$2.120M
YoY Change	77.86%	1709.28%	110.69%
Total Short-Term Liabilities	$19.61M	$17.68M	$15.09M
YoY Change	93.59%	304.34%	186.74%
LONG-TERM LIABILITIES
Long-Term Debt	$16.25M	$18.95M	$24.42M
YoY Change	83.0%	75188.04%	91121.52%
Other Long-Term Liabilities	$160.0K	$450.0K	$380.0K
YoY Change	-76.49%	33.04%	-3.82%
Total Long-Term Liabilities	$16.41M	$19.40M	$24.80M
YoY Change	71.36%	5238.8%	5778.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.61M	$17.68M	$15.09M
Total Long-Term Liabilities	$16.41M	$19.40M	$24.80M
Total Liabilities	$36.02M	$37.08M	$39.71M
YoY Change	82.78%	682.93%	598.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.20M	-$7.843M
YoY Change	269.98%	115.09%
Common Stock	$20.22K	$18.09K
YoY Change	20.96%	12.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.84M	$37.03M	$36.92M
YoY Change
Total Liabilities & Shareholders Equity	$63.85M	$73.81M	$76.64M
YoY Change	31.68%	122.65%	117.7%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$15.36M	-$1.769M	$2.584M
YoY Change	486.26%	3258.25%	3885.78%
Depreciation, Depletion And Amortization	$950.0K	$232.5K	$1.200M
YoY Change	-24.0%	61.97%	814.46%
Cash From Operating Activities	-$3.320M	-$70.00K	$6.100M
YoY Change	101.21%	-107.34%	1443.33%
INVESTING ACTIVITIES
Capital Expenditures	$660.0K	$100.0K	$30.00K
YoY Change	32.0%	-117.3%	-100.61%
Acquisitions
YoY Change
Other Investing Activities	$730.0K	-$5.780M	$5.910M
YoY Change	-170.87%	1070.04%	-406.41%
Cash From Investing Activities	$80.00K	-$5.880M	$5.880M
YoY Change	-105.19%	448.49%	-186.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.550M	2.620M	-10.77M
YoY Change	12.35%	-232.67%	1076900.0%
NET CHANGE
Cash From Operating Activities	-3.320M	-70.00K	6.100M
Cash From Investing Activities	80.00K	-5.880M	5.880M
Cash From Financing Activities	6.550M	2.620M	-10.77M
Net Change In Cash	3.310M	-3.330M	1.210M
YoY Change	25.38%	59.1%	-118.79%
FREE CASH FLOW
Cash From Operating Activities	-$3.320M	-$70.00K	$6.100M
Capital Expenditures	$660.0K	$100.0K	$30.00K
Free Cash Flow	-$3.980M	-$170.0K	$6.070M
YoY Change	85.12%	-111.1%	14.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001775194
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	500000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	500000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16713345	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18094748	shares
CY2023Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	124804	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	358390	usd
CY2022Q4	upxi	Stock Based Compensation Expense StockBasedCompensationExpense	1052847	usd
	upxi	Estimated Forfeitures Percentage Rate EstimatedForfeituresPercentageRate	0	pure
	upxi	Estimated Forfeitures Percentage Rate EstimatedForfeituresPercentageRate	0	pure
CY2021Q4	upxi	Stock Based Compensation Expense StockBasedCompensationExpense	852455	usd
	upxi	Stock Based Compensation Expense StockBasedCompensationExpense	1479293	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-255266
	dei	Entity Registrant Name EntityRegistrantName	UPEXI, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3378978
	dei	Entity Address Address Line1 EntityAddressAddressLine1	17129 US Hwy 19 N
	dei	Entity Address City Or Town EntityAddressCityOrTown	Clearwater
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33760
	dei	City Area Code CityAreaCode	701
	dei	Local Phone Number LocalPhoneNumber	353-5425
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
	dei	Trading Symbol TradingSymbol	UPXI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18094748	shares
CY2023Q1	us-gaap	Cash Cash	1181042	usd
CY2022Q2	us-gaap	Cash Cash	7149806	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5346853	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1137637	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	10140644	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	4725685	usd
CY2023Q1	upxi	Due From Bloomios DueFromBloomios	1617216	usd
CY2022Q2	upxi	Due From Bloomios DueFromBloomios	0	usd
CY2023Q1	upxi	Deferred Tax Asset Current DeferredTaxAssetCurrent	0	usd
CY2022Q2	upxi	Deferred Tax Asset Current DeferredTaxAssetCurrent	462070	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1809730	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	840193	usd
CY2023Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	6449210	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	20095485	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	20764601	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7618148	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7343783	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17312833	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10641382	usd
CY2023Q1	us-gaap	Goodwill Goodwill	15056856	usd
CY2022Q2	us-gaap	Goodwill Goodwill	5887393	usd
CY2023Q1	upxi	Deferred Tax Assets Net Noncurrent Amount DeferredTaxAssetsNetNoncurrentAmount	2979918	usd
CY2022Q2	upxi	Deferred Tax Assets Net Noncurrent Amount DeferredTaxAssetsNetNoncurrentAmount	2002759	usd
CY2023Q1	us-gaap	Investments Investments	9955450	usd
CY2022Q2	us-gaap	Investments Investments	0	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	118040	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	100372	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	678145	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	926570	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	53719390	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	26902259	usd
CY2023Q1	us-gaap	Assets Assets	73814875	usd
CY2022Q2	us-gaap	Assets Assets	47666860	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2635876	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2018541	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	889634	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	531259	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	48162	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	105848	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4172455	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	955327	usd
CY2023Q1	upxi	Acquisition Payable AcquisitionPayable	500000	usd
CY2022Q2	upxi	Acquisition Payable AcquisitionPayable	0	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	9164189	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	5424752	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	272116	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	267029	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17682429	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9302756	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	449874	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	700411	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	18951762	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	8876949	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	19401636	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9577360	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	500000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18094748	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16713345	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	18094	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	16713	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	44858392	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34985597	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7842606	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6270886	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	37034380	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	28731924	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-303570	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	54820	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36730810	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28786744	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73814875	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47666860	usd
CY2023Q1	us-gaap	Revenues Revenues	24219445	usd
CY2022Q1	us-gaap	Revenues Revenues	4426898	usd
	us-gaap	Revenues Revenues	62863128	usd
	us-gaap	Revenues Revenues	13280565	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	14614754	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1098137	usd
	us-gaap	Cost Of Revenue CostOfRevenue	36904527	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3081112	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	9604691	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	3328761	usd
	us-gaap	Gross Profit GrossProfit	25958601	usd
	us-gaap	Gross Profit GrossProfit	10199453	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3476918	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1085823	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9210303	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3821081	usd
CY2023Q1	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	2578180	usd
CY2022Q1	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	605368	usd
	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	8641559	usd
	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	1538830	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2878255	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1970276	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8287779	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6556627	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1146299	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	854013	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3126472	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2333306	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1691243	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	236001	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3534216	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	540836	usd
CY2023Q1	us-gaap	Depreciation Depreciation	232492	usd
CY2022Q1	us-gaap	Depreciation Depreciation	115011	usd
	us-gaap	Depreciation Depreciation	669540	usd
	us-gaap	Depreciation Depreciation	361590	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	12003387	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4866492	usd
	us-gaap	Operating Expenses OperatingExpenses	33469869	usd
	us-gaap	Operating Expenses OperatingExpenses	15152270	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2398696	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1537731	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7511268	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4952817	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-154999	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-19705	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2380972	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-61699	usd
CY2023Q1	upxi	Change In Derivative Liability ChangeInDerivativeLiability	0	usd
	upxi	Change In Derivative Liability ChangeInDerivativeLiability	0	usd
	upxi	Change In Derivative Liability ChangeInDerivativeLiability	-1770	usd
CY2022Q1	upxi	Change In Derivative Liability ChangeInDerivativeLiability	0	usd
CY2023Q1	upxi	Gain On Sale Of Infusionz And Select Assets GainOnSaleOfInfusionzAndSelectAssets	0	usd
CY2022Q1	upxi	Gain On Sale Of Infusionz And Select Assets GainOnSaleOfInfusionzAndSelectAssets	0	usd
	upxi	Gain On Sale Of Infusionz And Select Assets GainOnSaleOfInfusionzAndSelectAssets	7564363	usd
	upxi	Gain On Sale Of Infusionz And Select Assets GainOnSaleOfInfusionzAndSelectAssets	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5500	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5500	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	300995	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	154999	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14205	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5181621	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-244796	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2553695	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1551936	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2329647	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4708021	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-496880	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1351686	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-449828	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1116653	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2056815	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-200250	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1879819	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3591368	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	288127	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	147583	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-50291	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4115245	usd
CY2022Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1643884	usd
CY2022Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-52667	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1571720	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	523877	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.22
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.02
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.26
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.20
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.02
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.23
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18015837	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16426399	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17418877	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16080699	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18015837	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17821810	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17418877	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17586030	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21217973	usd
CY2021Q3	upxi	Issuance Of Common Stock For Acquisition Of Infusionz Amount IssuanceOfCommonStockForAcquisitionOfInfusionzAmount	1764876	usd
CY2021Q3	upxi	Issuance Of Common Stock For Acquisition Of Vitamedica Amount IssuanceOfCommonStockForAcquisitionOfVitamedicaAmount	482000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	33740	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	593098	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	175000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	511711	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24778398	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	677455	usd
CY2021Q4	upxi	Issuance Of Common Stock For Acquisition Of Interactive Offers Amount IssuanceOfCommonStockForAcquisitionOfInteractiveOffersAmount	4000000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	64833	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29520686	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	670098	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1975888	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2022Q1	upxi	Issuance Of Common Stock For Stock Compensation Amount IssuanceOfCommonStockForStockCompensationAmount	183915	usd
CY2022Q1	upxi	Issuance Of Common Stock For Stock Compensation For Building Remodel Amount IssuanceOfCommonStockForStockCompensationForBuildingRemodelAmount	70350	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-52667	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28416494	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28786744	usd
CY2022Q3	upxi	Amortization Of Common Stock Issuance For Services AmortizationOfCommonStockIssuanceForServices	70350	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	927326	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2745520	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27038900	usd
CY2022Q4	upxi	Amortization Of Common Stock Issuance For Services AmortizationOfCommonStockIssuanceForServices	70350	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1052847	usd
CY2022Q4	upxi	Issuance Of Common Stock For Acquisition Of E Core Amount IssuanceOfCommonStockForAcquisitionOfECoreAmount	6000000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2584098	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36746195	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1146299	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	607004	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1768688	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36730810	usd
	us-gaap	Profit Loss ProfitLoss	1571720	usd
	us-gaap	Profit Loss ProfitLoss	-523877	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4203756	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	902426	usd
	upxi	Gain On Sale Of Infusionz And Select Assets GainOnSaleOfInfusionzAndSelectAssets	7564363	usd
	upxi	Gain On Sale Of Infusionz And Select Assets GainOnSaleOfInfusionzAndSelectAssets	0	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	5500	usd
	us-gaap	Inventory Write Down InventoryWriteDown	34328	usd
	us-gaap	Inventory Write Down InventoryWriteDown	140000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	usd
	upxi	Accrued Interest On Note Receivable From Bloomios AccruedInterestOnNoteReceivableFromBloomios	-141635	usd
	upxi	Accrued Interest On Note Receivable From Bloomios AccruedInterestOnNoteReceivableFromBloomios	0	usd
	upxi	Amortization Of Senior Security Original Issue Discount AmortizationOfSeniorSecurityOriginalIssueDiscount	-455450	usd
	upxi	Amortization Of Senior Security Original Issue Discount AmortizationOfSeniorSecurityOriginalIssueDiscount	0	usd
	upxi	Uncollected Transition Fees From Bloomios UncollectedTransitionFeesFromBloomios	-428500	usd
	upxi	Uncollected Transition Fees From Bloomios UncollectedTransitionFeesFromBloomios	0	usd
	upxi	Noncontrolling Interest NoncontrollingInterest	-358390	usd
	upxi	Noncontrolling Interest NoncontrollingInterest	0	usd
	upxi	Change In Deferred Tax Asset ChangeInDeferredTaxAsset	515089	usd
	upxi	Change In Deferred Tax Asset ChangeInDeferredTaxAsset	-156204	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	358915	usd
	upxi	Shares Issued For Finder Fee SharesIssuedForFinderFee	1770	usd
	upxi	Shares Issued For Finder Fee SharesIssuedForFinderFee	33740	usd
	upxi	Stock Issued During Period Value Share Based Compensation Total StockIssuedDuringPeriodValueShareBasedCompensationTotal	-3126472	usd
	upxi	Stock Issued During Period Value Share Based Compensation Total StockIssuedDuringPeriodValueShareBasedCompensationTotal	-1940651	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2490729	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21735	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2293866	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	604325	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	28090	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-533103	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2975	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-17062	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2488065	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	731726	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-57686	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	85030	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3521038	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4801520	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2634975	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3521038	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2166545	usd
	upxi	Payment To Acquire Lucky Tail PaymentToAcquireLuckyTail	3012327	usd
	upxi	Payment To Acquire Lucky Tail PaymentToAcquireLuckyTail	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	500000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2574589	usd
	upxi	Acquisition Of New England Technology Inc AcquisitionOfNewEnglandTechnologyInc	2085390	usd
	upxi	Acquisition Of New England Technology Inc AcquisitionOfNewEnglandTechnologyInc	0	usd
	us-gaap	Acquisition Costs AcquisitionCosts	1050000	usd
	us-gaap	Acquisition Costs AcquisitionCosts	0	usd
	upxi	Acquisition Of Interative Offers Net Of Cash Acquired AcquisitionOfInterativeOffersNetOfCashAcquired	0	usd
	upxi	Acquisition Of Interative Offers Net Of Cash Acquired AcquisitionOfInterativeOffersNetOfCashAcquired	1854193	usd
	upxi	Proceeds From The Sale Of Infusionz And Selected Assets ProceedsFromTheSaleOfInfusionzAndSelectedAssets	4273427	usd
	upxi	Proceeds From The Sale Of Infusionz And Selected Assets ProceedsFromTheSaleOfInfusionzAndSelectedAssets	6000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	278683	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5649100	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2652973	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10071882	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2652973	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10071882	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	470168	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	usd
	upxi	Repayments Of Notes Payable Sba RepaymentsOfNotesPayableSBA	254804	usd
	upxi	Repayments Of Notes Payable Sba RepaymentsOfNotesPayableSBA	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	6307775	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	6826338	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	upxi	Proceeds On Note Payable On Building ProceedsOnNotePayableOnBuilding	3000000	usd
	upxi	Proceeds On Note Payable On Building ProceedsOnNotePayableOnBuilding	0	usd
	upxi	Proceeds From Stock Repurchase Program ProceedsFromStockRepurchaseProgram	0	usd
	upxi	Proceeds From Stock Repurchase Program ProceedsFromStockRepurchaseProgram	-1975888	usd
	upxi	Repayment On Note Payable On Building RepaymentOnNotePayableOnBuilding	97744	usd
	upxi	Repayment On Note Payable On Building RepaymentOnNotePayableOnBuilding	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2650000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1470000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-6836829	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2125888	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6836829	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2125888	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5968764	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7396250	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	-2634975	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7149806	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14534211	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1181042	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4502986	usd
	us-gaap	Interest Paid Net InterestPaidNet	326918	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	upxi	Issuance Of Common Stock For Acquisition Of Infusionz IssuanceOfCommonStockForAcquisitionOfInfusionz	0	usd
	upxi	Issuance Of Common Stock For Acquisition Of Infusionz IssuanceOfCommonStockForAcquisitionOfInfusionz	1764876	usd
	upxi	Issuance Of Debt For Acquisition Of Vitamedica IssuanceOfDebtForAcquisitionOfVitamedica	0	usd
	upxi	Issuance Of Common Stock For Acquisition Of Vitamedica IssuanceOfCommonStockForAcquisitionOfVitamedica	482000	usd
	upxi	Issuance Of Common Stock For Acquisition Of Vitamedica IssuanceOfCommonStockForAcquisitionOfVitamedica	0	usd
	upxi	Issuance Of Debt For Acquisition Of Vitamedica IssuanceOfDebtForAcquisitionOfVitamedica	1000000	usd
	upxi	Liabilities Assumed From Acquisition Of Luckytail LiabilitiesAssumedFromAcquisitionOfLuckytail	0	usd
	upxi	Liabilities Assumed From Acquisition Of Luckytail LiabilitiesAssumedFromAcquisitionOfLuckytail	0	usd
	upxi	Issuance Of Common Stock For Acquisition Of E Core IssuanceOfCommonStockForAcquisitionOfECore	6000000	usd
	upxi	Issuance Of Common Stock For Acquisition Of E Core IssuanceOfCommonStockForAcquisitionOfECore	0	usd
	upxi	Liabilities Assumed From Acquisition Of E Core LiabilitiesAssumedFromAcquisitionOfECore	-7712168	usd
	upxi	Liabilities Assumed From Acquisition Of E Core LiabilitiesAssumedFromAcquisitionOfECore	0	usd
	upxi	Non Cash Consideration Received From Bloomios For The Sale Of Infusionz NonCashConsiderationReceivedFromBloomiosForTheSaleOfInfusionz	18000000	usd
	upxi	Non Cash Consideration Received From Bloomios For The Sale Of Infusionz NonCashConsiderationReceivedFromBloomiosForTheSaleOfInfusionz	0	usd
	upxi	Operating Assets Designated As Held For Sale OperatingAssetsDesignatedAsHeldForSale	6446210	usd
	upxi	Operating Assets Designated As Held For Sale OperatingAssetsDesignatedAsHeldForSale	6786289	usd
	upxi	Liabilities Assumed From Acquisition Of Vitamedica LiabilitiesAssumedFromAcquisitionOfVitamedica	0	usd
	upxi	Liabilities Assumed From Acquisition Of Vitamedica LiabilitiesAssumedFromAcquisitionOfVitamedica	-309574	usd
	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	4000000	shares
	upxi	Liabilities Assumed From Acquisition Of Interactive LiabilitiesAssumedFromAcquisitionOfInteractive	0	usd
	upxi	Liabilities Assumed From Acquisition Of Interactive LiabilitiesAssumedFromAcquisitionOfInteractive	-1099993	usd
CY2022Q2	us-gaap	Investments And Cash InvestmentsAndCash	1950000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	8500000	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	56789561	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	5114888	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	24690597	usd
CY2022Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1855605	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	50329	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10140644	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4725685	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	34328	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Inventory Write Down InventoryWriteDown	140000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9284430	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8211689	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	1666282	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	867906	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7618148	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7343783	usd
CY2023Q1	upxi	Depreciation Expense DepreciationExpense	232492	usd
CY2022Q1	upxi	Depreciation Expense DepreciationExpense	143537	usd
	upxi	Depreciation Expense DepreciationExpense	669540	usd
	upxi	Depreciation Expense DepreciationExpense	390116	usd
CY2023Q1	upxi	Amortization Intangible Assets AmortizationIntangibleAssets	1691243	usd
CY2022Q1	upxi	Amortization Intangible Assets AmortizationIntangibleAssets	417549	usd
	upxi	Amortization Intangible Assets AmortizationIntangibleAssets	3534216	usd
	upxi	Amortization Intangible Assets AmortizationIntangibleAssets	1085481	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	840193	usd
	upxi	Lease Term LeaseTerm	1 year to 5 years
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	366370	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	153458	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	94255	usd
	upxi	Schedule Of Intangible Assets One Tabletextblock ScheduleOfIntangibleAssetsOneTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Cost</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Accumulated</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Amortization</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Net</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Book Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Customer relationships, amortized over four years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,092,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">689,292</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,402,708</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Trade name, amortized over five years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">609,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">156,783</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">452,217</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Non-compete agreements, amortized over the term of the agreement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">275,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">115,042</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">159,958</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Online sales channels, amortized over two years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,800,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">225,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,575,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Vender relationships, amortized over five years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">300,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,700,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Software, amortized over five years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,590,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">238,500</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,351,500</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">12,366,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">1,724,617</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">10,641,383</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	2092000	usd
CY2022Q2	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	609000	usd
CY2022Q2	us-gaap	Finite Lived Noncompete Agreements Gross FiniteLivedNoncompeteAgreementsGross	275000	usd
CY2022Q2	upxi	Intangible Assets Online Sales Channels IntangibleAssetsOnlineSalesChannels	1800000	usd
CY2022Q2	upxi	Intangible Assets Vendor Relationships IntangibleAssetsVendorRelationships	6000000	usd
CY2022Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1590000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12366000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1381700	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5240905	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4560800	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4560800	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1568628	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17312833	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1809730	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	120512	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	28684	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	763279	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	41289	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	721990	usd
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P29M
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	99101	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	285855	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	67088	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	233409	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	4595	usd
	us-gaap	Interest Expense Other InterestExpenseOther	25030	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	170784	usd
	us-gaap	Lease Cost LeaseCost	544294	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0	usd
CY2022Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	6418	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	504892	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	147887	usd
CY2023Q1	upxi	Accrued Vendor Liabilities AccruedVendorLiabilities	153468	usd
CY2022Q2	upxi	Accrued Vendor Liabilities AccruedVendorLiabilities	29960	usd
CY2023Q1	upxi	Accrued Expenses On Credit Cards AccruedExpensesOnCreditCards	476802	usd
CY2022Q2	upxi	Accrued Expenses On Credit Cards AccruedExpensesOnCreditCards	108735	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	155990	usd
CY2022Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	108425	usd
	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.2067	pure
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	81909	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1724110	usd
CY2022Q2	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	0	usd
CY2023Q1	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	1157193	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	471993	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4172455	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	955327	usd
CY2023Q1	upxi	Payments Related To The Acquisition Of Luckytail PaymentsRelatedToTheAcquisitionOfLuckytail	500000	usd
CY2022Q2	upxi	Payments Related To The Acquisition Of Luckytail PaymentsRelatedToTheAcquisitionOfLuckytail	0	usd
CY2023Q1	upxi	Total Total	500000	usd
CY2022Q2	upxi	Total Total	0	usd
CY2023Q1	upxi	Total Notes Payable TotalNotesPayable	28115951	usd
CY2023Q1	upxi	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	9164189	usd
CY2023Q1	upxi	Notes Payable Related Parties Current And Noncurrent1 NotesPayableRelatedPartiesCurrentAndNoncurrent1	18951762	usd
	upxi	Proceeds From Related Party ProceedsFromRelatedParty	600000	usd
CY2023Q1	upxi	Investment Owned Principal Amount InvestmentOwnedPrincipalAmount	2150000	usd
CY2023Q1	upxi	Issuance Of Restricted Stock Shares IssuanceOfRestrictedStockShares	134000	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.53
CY2023Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.1811	pure
CY2023Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	5.00
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	560000	usd
CY2023Q1	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.10	pure
CY2022Q2	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	1500000	usd
CY2022Q2	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.085	pure
CY2022Q2	upxi	Additional Percentage Rate Pik AdditionalPercentageRatePik	0.035	pure
CY2023Q1	upxi	Investment Principal Amount InvestmentPrincipalAmount	2150000	usd
	upxi	Maturity Of Restricted Common Stock MaturityOfRestrictedCommonStock	21-month term
CY2023Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.1811	pure
	upxi	Stock Issued During Period Acquisitions Amount StockIssuedDuringPeriodAcquisitionsAmount	35000	usd
	upxi	Stock Issued During Period Value Issue For Services StockIssuedDuringPeriodValueIssueForServices	175000	usd
	upxi	Common Stock For Prepayment Of Interest On Note Payable CommonStockForPrepaymentOfInterestOnNotePayable	134000	shares
	upxi	Stock Based Compensation Expense StockBasedCompensationExpense	1019883	usd
	upxi	Stock Based Compensation Expense StockBasedCompensationExpense	670098	usd
CY2023Q1	upxi	Income Tax Benefit And Expense IncomeTaxBenefitAndExpense	496880	usd
	upxi	Income Tax Benefit And Expense IncomeTaxBenefitAndExpense	449828	usd
CY2022Q1	upxi	Income Tax Benefit And Expense IncomeTaxBenefitAndExpense	1351686	usd
CY2023Q1	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	3600000	usd
	upxi	Income Tax Benefit And Expense IncomeTaxBenefitAndExpense	1116653	usd
CY2022Q2	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.085	pure

Files In Submission

Name	View Source	Status
upxi-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001477932-23-003603-index-headers.html	Edgar Link	pending
0001477932-23-003603-index.html	Edgar Link	pending
0001477932-23-003603.txt	Edgar Link	pending
0001477932-23-003603-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
upxi-20230331.xsd	Edgar Link	pending
upxi_10q.htm	Edgar Link	pending
upxi_ex311.htm	Edgar Link	pending
upxi-20230331_def.xml	Edgar Link	unprocessable
upxi-20230331_lab.xml	Edgar Link	unprocessable
upxi-20230331_pre.xml	Edgar Link	unprocessable
upxi_10q_htm.xml	Edgar Link	completed
upxi_ex312.htm	Edgar Link	pending
upxi_ex321.htm	Edgar Link	pending
upxi_ex322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UPXI
Upexi Inc Stock $upxi

2023 Q2 Form 10-Q Financial Statement

#000147793223003603 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPXI Upexi Inc Stock $upxi

2023 Q2 Form 10-Q Financial Statement

#000147793223003603 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPXI
Upexi Inc Stock $upxi